MEET THE PUPS WHO BEAT THE ODDS
Six-year-old Roscoe was diagnosed with osteosarcoma in May 2017.
Instead of chemotherapy, he was enrolled in a clinical trial and received a new experimental T-cell infusion treatment.
And he is thriving today with no sign of cancer.
Codi went through surgery in August 2017 after bone cancer was found. He then received chemotherapy treatment. But by April 2018, the tumor had spread to his lungs.
His parents learned about a new cancer-fighting vaccine developed by Yale University professor and drove him to Connecticut. The tumors in his lungs disappeared after CODI received the cancer vaccine treatment, and he is still with his parents enjoying life in New Jersey.
These and other dogs beat osteosarcoma with experimental immunotherapy
Immunotherapy activates the immune system to fight cancer. For some patients, it can induce long-term remission and even reversal of metastasis. Can more patients be helped with immunotherapy?
CCRA supports research into new treatments that have the potential to be far superior to today's therapies.
Immunotherapy is one of the areas of our focus.
Unlike chemotherapy that kills cancer cells directly, immunotherapy activates the dog's own immune cells to fight cancer. It's an approach with potentially fewer side-effects and greater efficacy.
The big challenge for researchers is figuring out how to help more dogs respond like CODI and ROSCOE.